Standard

Medication use (agents acting on the renin-angiotensin system)

RP4-662A9.2 · rs2105092

What each result means

A/A Published research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Medication use (agents acting on the renin-angiotensin system) compared to the general population. (GWAS Catalog, Nat Commun 2019, PMID:31015401)
A/G Published research associates this genotype (one copy of the reported risk allele) with an intermediate association with Medication use (agents acting on the renin-angiotensin system). (GWAS Catalog, Nat Commun 2019, PMID:31015401)
G/G Published research associates this genotype with typical/baseline likelihood of Medication use (agents acting on the renin-angiotensin system) — no copies of the reported risk allele. (GWAS Catalog, Nat Commun 2019, PMID:31015401)

Source: GWAS Catalog, Nat Commun 2019, PMID:31015401

Questions about rs2105092

What is rs2105092?

rs2105092 is a single position in the genome, in or near the RP4-662A9.2 gene. Published research associates it with medication use (agents acting on the renin-angiotensin system). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

Does having rs2105092 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs2105092 come from?

GWAS Catalog, Nat Commun 2019, PMID:31015401. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

← See all variants